July 19, 2023 02:57 PM EDTUpdated July 20, 07:04 AM
Pharma
Law

SEC fines for­mer Mer­ck ex­ec over in­sid­er trad­ing al­le­ga­tions

Paul Schloesser

Associate Editor

The Se­cu­ri­ties and Ex­change Com­mis­sion said a for­mer Mer­ck ex­ec­u­tive agreed to pay $82,000 af­ter al­leg­ing he pur­chased shares of a com­pa­ny right be­fore it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

A service from the Financial Times